The $4.3 Billion Deal That Blew Up Over Shoddy Drug Production

Bookmark
(Bloomberg) -- Shortly after Fresenius SE made a $4.3 billion takeover offer for Akorn Inc. in April 2017, it sent a squadron of lawyers and consultants to comb through the generic drugmaker’s reco...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.